TBCRC 002: A phase II, randomized, open label trial of preoperative letrozole versus letrozole (LET) in combination with bevacizumab (BEV) in post-menopausal women with newly diagnosed stage II/III breast cancer.
Andres Forero-Torres
Research Funding - Genentech; Novartis
Hope S. Rugo
Research Funding - Genentech/Roche; Novartis
Christos Vaklavas
No relevant relationships to disclose
Nancy U. Lin
Research Funding - Genentech
Lisa A. Carey
Research Funding - Genentech; Novartis
Minetta C. Liu
Honoraria - Genentech
Research Funding - Genentech
Rita Nanda
Research Funding - Genentech
Shannon Puhalla
No relevant relationships to disclose
Anna Maria Storniolo
No relevant relationships to disclose
Helen Krontiras
No relevant relationships to disclose
Mansoor N. Saleh
Research Funding - Genentech
Yufeng Li
No relevant relationships to disclose
Albert F. LoBuglio
No relevant relationships to disclose
Jennifer F. De Los Santos
No relevant relationships to disclose